Skip to content

Clinical trials

Phase 3 Diabetes Mellitus trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Phase 3 Country / region: United Kingdom Clear all

96 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20023
20034
20044
20053
20069
20074
20084
200913
20106
20114
20124
20136
20143
20151
20167
20175
20183
20201
20211
20222
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed82
Terminated8
Active, not recruiting5
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S50
AstraZeneca10
Eli Lilly and Company6
Takeda6
GlaxoSmithKline5
Allergan3
Pfizer3
Bristol-Myers Squibb1
Diamyd Therapeutics AB1
Ixaka Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus96
Diabetes Mellitus, Type 264
Diabetes Mellitus, Type 123
Glucose Metabolism Disorders10
Metabolic Diseases7
Endocrine System Diseases5
Cardiovascular Diseases4
Dyslipidemias4
Obesity4
Gastroparesis3

Trials

Showing 1 to 25 of 96. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.